Farmacia y Drogas carries out consultations to update the regulary framework of Law 1 on drugs

The National Director of Pharmacy and Drugs of the Ministry of Health Elvia Lau, reported that a review of the regulatory framework of Law 1 on drugs of 2001 was carried out in order to strengthen the regulations according to advances in science and technology.

He said that all regulatory authorities in the world are constantly reviewing their regulations because technical and scientific changes arise every year, which makes it necessary to undergo a constant evaluation process.

In that sense, the Pharmacy and Drugs management carried out an exhaustive review of the regulatory framework where they concluded that the regulation of Law 1 of 2001 requires updating and that is what will be carried out, Lau said.

According to Lau, this regulation has been sent to national and international consultation where all the parties involved can send their proposals by accessing the MINSA website, in the Pharmacy and Drugs section at the link: Matrix for Consultation Observations Public; In this form the observations must be placed in the article to which they are referring, their proposal and the justification of the same since they must be within the regulatory framework and that it does not affect the Central American technical regulations to which Panama has consigned.

With the review and the proposals, what is sought is to update the regulations of Law 1 on drugs of 2001 in a meticulous way by a committee that will be led by the Department of Pharmacy and Drugs of the MINSA, with the participation of representatives of national laboratories and international companies, distributors, processors and members of the national college of pharmacists, which after a period of 60 days from the issuance of the proposals, will have the power to verify the viability to accept or reject it, the official said.

Finally, Lau indicated that in the national drug policy there is that duty to remain in a constant review of the regulatory framework and verify if it is in accordance with reality or has remained in time, and reiterated that this document covers everything related to pharmacovigilance, quality audit, controlled substances, health registry, pharmacotherapy and all medicines that are imported into the country.